Hybrid training in nuclear medicine: where are we going to? Marcel P. M. StokkelEmilia C. Owers Editorial 13 April 2023 Pages: 2231 - 2235
Nuclear imaging and therapy in oncology in Poland in 2021–2022 Jolanta KunikowskaLeszek KrólickiRafał Czepczyński Editorial 11 April 2023 Pages: 2236 - 2239
PD-L1 − targeted magnetic fluorescent hybrid nanoparticles: Illuminating the path of image-guided cancer immunotherapy Xiaoyan LiMuhsin H. YounisWeibo Cai Editorial 21 March 2023 Pages: 2240 - 2243
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery Cristiano PiniMaria PicchioPaola Mapelli Editorial 13 May 2023 Pages: 2244 - 2245
Beyond 68Ga-labeled somatostatin analogues: is it time to say goodbye to [68Ga]DOTA-conjugated peptides for neuroendocrine neoplasms? Gaia NinattiPaola Mapelli Editorial 24 May 2023 Pages: 2246 - 2247
Large language models (LLM) and ChatGPT: a medical student perspective Arosh S. Perera Molligoda Arachchige Letter to the Editor 13 April 2023 Pages: 2248 - 2249
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting Hong SongValentina FerriAndrei Iagaru Original Article 04 March 2023 Pages: 2250 - 2257
Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT Joyce van SluisRonald BoellaardAdrienne H. Brouwers Original Article Open access 22 March 2023 Pages: 2258 - 2270
One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study Guobing LiuWujian MaoHongcheng Shi Original Article 27 March 2023 Pages: 2271 - 2281
Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective Manon T. A. VreeburgSamaneh AzargoshasbDaphne D. D. Rietbergen Original Article Open access 17 March 2023 Pages: 2282 - 2291
Deep learning for improving PET/CT attenuation correction by elastic registration of anatomical data Joshua SchaefferkoetterVijay ShahSven Zuehlsdorff Original Article 08 March 2023 Pages: 2292 - 2304
Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer Yitai XiaoChaoming MeiDan Li Original Article 14 March 2023 Pages: 2305 - 2318
SPECT and CT misregistration reduction in [99mTc]Tc-MAA SPECT/CT for precision liver radioembolization treatment planning Zhonglin LuGefei ChenGreta S. P. Mok Original Article 06 March 2023 Pages: 2319 - 2330
A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy Tianhong YangLei PengZhihao Zha Original Article Open access 03 March 2023 Pages: 2331 - 2341
[177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy Qiaomiao LuYu LongXiaoli Lan Original Article 06 March 2023 Pages: 2342 - 2352
Radionuclide-based theranostics — a promising strategy for lung cancer Tianxing ZhuJessica C. HsuKai Wang Review Article 16 March 2023 Pages: 2353 - 2374
An exploration of the feasibility and clinical value of half-dose 5-h total-body 18F-FDG PET/CT scan in patients with Takayasu arteritis Dilibire AdiliDanjie CaiHongcheng Shi Original Article 03 March 2023 Pages: 2375 - 2385
First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2 Yong DuJennifer M. CoughlinMartin G. Pomper Original Article 06 March 2023 Pages: 2386 - 2393
Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis Jingguo WangJingjie GeXiangjun Chen Original Article 17 March 2023 Pages: 2394 - 2408
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study Denise VisserSander C. J. VerfaillieRik Ossenkoppele Original Article Open access 28 March 2023 Pages: 2409 - 2419
Comparison of [18F]-OC PET/CT and contrast-enhanced CT/MRI in the detection and evaluation of neuroendocrine neoplasms Donghe ChenShuye YangXinhui Su Original Article 27 March 2023 Pages: 2420 - 2431
Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma Stephan P. M. SouzaFernanda C. FrassonCelso D. Ramos Original Article 29 March 2023 Pages: 2432 - 2440
A multi-label CNN model for the automatic detection and segmentation of gliomas using [18F]FET PET imaging Masoomeh RahimpourRonald BoellaardMichel Koole Original Article 18 March 2023 Pages: 2441 - 2452
Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections Feredun AzariKevin ZhangSunil Singhal Original Article 11 March 2023 Pages: 2453 - 2465
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment Adrien HolzgreveJulian TaugnerFarkhad Manapov Original Article Open access 23 March 2023 Pages: 2466 - 2476
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study Gianluca BottoniFrancesco FizArnoldo Piccardo Original Article 07 March 2023 Pages: 2477 - 2485
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study Mercedes MitjavilaPaula Jimenez-FonsecaAlberto Carmona-Bayonas Original Article Open access 06 March 2023 Pages: 2486 - 2500
Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study Zhiyuan BoBo ChenGang Chen Original Article 16 March 2023 Pages: 2501 - 2513
Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer François LuciaVincent BourbonnePierre Lovinfosse Original Article 09 March 2023 Pages: 2514 - 2528
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml Nantia SolomonidouDaphnie GermanouConstantinos Zamboglou Original Article Open access 11 March 2023 Pages: 2529 - 2536
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy Simon K. B. SpohnNina-Sophie Schmidt-HegemannJan C. Peeken Original Article Open access 16 March 2023 Pages: 2537 - 2547
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer Samuele GhezzoPaola MapelliMaria Picchio Original Article 18 March 2023 Pages: 2548 - 2560
Trigeminal nerve perineural invasion by an adenoid cystic carcinoma of the maxillary sinus, detected by 68Ga-PSMA Nikolina NovoselskaNikolay NedevPavel Bochev Image of the Month 28 February 2023 Pages: 2561 - 2562
[18F]mFBG long axial field of view PET-CT without general anaesthesia reveals concise extension of neuroblastoma in a 9-month-old boy L. BorgwardtJ. S. BrokB. M. Fischer Image of the Month Open access 28 February 2023 Pages: 2563 - 2564
Extranodal Rosai-Dorfman disease involving pulmonary artery detected by 68Ga-FAPI PET/CT and fused 68Ga-FAPI PET/MRI Liang ZhaoYizhen PangHaojun Chen Image of the Month 28 February 2023 Pages: 2565 - 2566
Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer 18FDG and 68Ga-FAPI PET/CT Mathias MeetschenPatrick SandachMarcel Opitz Image of the Month Open access 13 March 2023 Pages: 2567 - 2569
Correction to: Deep learning for improving PET/CT attenuation correction by elastic registration of anatomical data Joshua SchaefferkoetterVijay ShahSven Zuehlsdorff Correction Open access 25 March 2023 Pages: 2570 - 2570